Review of the Utility of Prophylactic Anticonvulsant Use in Critically Ill Patients With Intracerebral Hemorrhage.
From the Division of Neurocritical Care and Emergency Neurology (E.J.G., C.B.M., K.N.S.), and Division of Epilepsy (L.J.H.); Department of Neurology, Yale-New Haven Hospital, Yale School of Medicine, CT. emily.gilmore@yale.edu.
Emily J
EJ
Gilmore
From the Division of Neurocritical Care and Emergency Neurology (E.J.G., C.B.M., K.N.S.), and Division of Epilepsy (L.J.H.); Department of Neurology, Yale-New Haven Hospital, Yale School of Medicine, CT.
Carolina B
CB
Maciel
From the Division of Neurocritical Care and Emergency Neurology (E.J.G., C.B.M., K.N.S.), and Division of Epilepsy (L.J.H.); Department of Neurology, Yale-New Haven Hospital, Yale School of Medicine, CT.
Lawrence J
LJ
Hirsch
From the Division of Neurocritical Care and Emergency Neurology (E.J.G., C.B.M., K.N.S.), and Division of Epilepsy (L.J.H.); Department of Neurology, Yale-New Haven Hospital, Yale School of Medicine, CT.
Kevin N
KN
Sheth
D000927:Anticonvulsants / Q000627:therapeutic use*; D002543:Cerebral Hemorrhage / Q000150:complications*; D003422:Critical Care; D016638:Critical Illness; D006801:Humans; D012640:Seizures / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*
D000927:Anticonvulsants
anticonvulsants; cerebral hemorrhage; seizures; stroke